Australian Clinical Labs Limited (ASX:ACL) Plans $0.04 Interim Dividend

Australian Clinical Labs Limited (ASX:ACL) declared a interim dividend on Tuesday, February 17th, MarketIndexAU Dividends reports. Investors of record on Monday, March 30th will be paid a dividend of 0.037 per share on Monday, March 30th. This represents a dividend yield of 170.0%. The ex-dividend date of this dividend is Wednesday, March 11th.

Australian Clinical Labs Stock Performance

The company has a current ratio of 0.64, a quick ratio of 0.53 and a debt-to-equity ratio of 174.00. The stock has a market capitalization of $728.27 million, a price-to-earnings ratio of 30.38, a PEG ratio of -0.36 and a beta of 1.18.

About Australian Clinical Labs

Australian Clinical Labs Limited provides pathology services in Australia. The company offers range of services, which include routine pathology test, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology, and cytopathology; hematology, allergy, and immunology; serology and microbiology; and infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing services.